Loading...
Mirati Therapeutics, Inc.
MRTX•NASDAQ
Healthcare
Biotechnology
$58.70
$-0.10(-0.17%)
Mirati Therapeutics, Inc. (MRTX) Quarterly Earnings Reports & Financial Results
Analyze Mirati Therapeutics, Inc.’s revenue, EPS, and earnings surprises to assess performance and investor sentiment over recent quarters.
Total Reports
0
Avg EPS
N/A
Avg Revenue
N/A
Beats Estimates
0 out of 0
Max EPS
N/A
Min EPS
N/A
Earnings Visualization
Visual comparison of Mirati Therapeutics, Inc.’s actual vs. estimated earnings across recent quarters.
No data available
Mirati Therapeutics, Inc. (MRTX) Quarterly Earnings Details
Detailed breakdown of Mirati Therapeutics, Inc.’s earnings per share (EPS), revenue estimates vs. actuals, and earnings surprises by quarter.